The Valley Desk

ArticleTranslational neurodegenerationPublished

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Translational neurodegeneration
Published
Subject terms
Brain; Lewy Bodies; Animals; Mice, Transgenic; Humans; Mice; Mutation; Dopaminergic Neurons; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Transmission; G2019s; Genetic Risk
PubMed ID
38438877
PubMed Central ID
PMC10910783
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal